Clinical Trial Update: Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of CD07805/47 topical gel for erythematotelangiectatic rosacea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythematotelangiectatic Rosacea

Drugs mentioned

• CD07805/47 Topical Gel (CD07805/47 topical gel)

Snippet

Sponsor: Galderma R&D | Conditions: Erythematotelangiectatic Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2013-11-21